Mosaic Therapeutics
Mosaic’s use of advanced computational methods, while combining mining of large datasets with experimental approaches to identify and develop novel targeted therapies, completely reinvents the traditional approach to target and drug discovery
Cambridge, UKmosaic-tx.com ↗
Total raised
€25M
€25,045,281
Funding rounds
1
Investors
2
distinct backers
Active since
2023-04
latest 2023-04
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood32
base rate 44% for Series A
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-04-06 | Series A | €25M | Cambridge Innovation Capital,Syncona Investment Management | View deal → |
Related news
- Cancer drug discovery firm closes £22m Series A raisebusinesscloud.co.uk · 2023-04